Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines-does scheduling matter?

International Journal of Radiation Biology

Volumn 89, Issue 9, 2013, Pages 692-697

  Harrabi, Semi ^a   Combs, Stephanie E ^a   Brons, Stephan ^a   Haberer, Thomas ^a   Debus, Jürgen ^a   Weber, Klaus Josef ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Chemo radiotherapy; Glioblastoma cells; Heavy ion irradiation; RBE

Indexed keywords

CARBON; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CHEMORADIOTHERAPY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; HUMAN; HUMAN CELL; IRRADIATION; LINEAR ENERGY TRANSFER; MULTIMODALITY CANCER THERAPY; PHOTON; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; THERAPY; WESTERN BLOTTING;

CARBON; CELL CYCLE; CELL LINE, TUMOR; CHEMORADIOTHERAPY; DACARBAZINE; GLIOBLASTOMA; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PHOTONS; RADIATION-SENSITIZING AGENTS;

EID: 84883471729     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2013.791406     Document Type: Article

References (18)

1. Chakravarti A, Erkkinen MG, Nestler U, Stupp R, Mehta M, Aldape K, Gilbert MR, Black PM, Loeffl er JS . 2006. Temozolomide-mediated radiation enhancement in glioblastoma: A report on underlying mechanisms . Clinical Cancer Research 12: 4738-4746
2. Chalmers AJ, Ruff EM, Martindale C, Lovegrove N, Short SC . 2009. Cytotoxic effects of temozolomide and radiation are additiveand schedule-dependent . International Journal of Radiation Oncology . Biology . Physics 75: 1511-1519
3. Combs S, Zipp L, Rieken S, Habermehl D, Brons S, Winter M, Haberer T, Debus J, Weber K-J . 2012. In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells . Radiation Oncology 7 : 9
4. Combs SE, Bohl J, Elsässer T, Weber K-J, Schulz-Ertner D, Debus J, Weyrather WK . 2009. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines . International Journal of Radiation Biology 85: 126-137
5. Fritz G, Tano K, Mitra S, Kaina B . 1991 . Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments . Molecular and Cellular Biology 11 : 4660-4668
6. Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefi t from temozolomide in glioblastoma . New England Journal of Medicine 352: 997-1003
7. Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, Kaina B, Weller M . 2006 . O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells . Journal of Neurochemistry 96 : 766-776
8. Kitabayashi H, Shimada H, Yamada S, Yasuda S, Kamata T, Ando K, Tsujii H, Ochiai T . 2006. Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation . Oncology Reports 15: 913-918
9. Kondo N, Takahashi A, Ono K, Ohnishi T . 2010. DNA damage induced by alkylating agents and repair pathways . Journal of Nucleic Acids 2010 (Article ID 543531).
10. Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, Stupp R . 2004. Plasma and cerebrospinal fl uid population pharmacokinetics of temozolomide in malignant glioma patients . Clinical Cancer Research 10: 3728-3736
11. Patel M, McCully C, Godwin K, Balis FM . 2003. Plasma and cerebrospinal fl uid pharmacokinetics of intravenous temozolomide in non-human primates . Journal of Neuro-Oncology 61 : 203-207
12. Quiros S, Roos WP, Kaina B . 2010. Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles . Cell Cycle 9 : 168-178
13. Roos WP, Batista LFZ, Naumann SC, Wick W, Weller M, Menck CFM, Kaina B . 2007 . Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine . Oncogene 26 : 186-197
14. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. 2005 . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma . New England Journal of Medicine 352: 987-996
15. van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ . 2000. Survival of human glioma cells treated with various combination of temozolomide and X-rays . International Journal of Radiation Oncology .*Biology .*Physics 47: 779-784
16. Walker MD, Strike TA, Sheline GE . 1979 . An analysis of dose-effect relationship in the radiotherapy of malignant gliomas . International Journal of Radiation Oncology . Biology .*Physics 5: 1725-1731
17. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, et al. 1980. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery . New England Journal of Medicine 303 : 1323-1329
18. Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES . 1997. In vitro evaluation of temozolomide combined with X-irradiation. Anti-Cancer Drugs 8 : 92-97